Homozygous cystathionine β-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis

被引:42
作者
Kluijtmans, LAJ
Boers, GHJ
Verbruggen, B
Trijbels, FJM
Nováková, IRO
Blom, HJ
机构
[1] Univ Nijmegen Hosp, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands
[2] Univ Nijmegen Hosp, Dept Pediat, NL-6500 HB Nijmegen, Netherlands
[3] Univ Nijmegen Hosp, Dept Haematol, Cent Lab Haematol, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
10.1182/blood.V91.6.2015.2015_2015_2018
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Severe hyperhomocysteinemia in its most frequent form, is caused by a homozygous enzymatic deficiency of cystathionine P-synthase (CBS). A major complication in CBS deficiency is deep venous thrombosis or pulmonary embolism. A recent report by Mandel et al (N Engl J Med 334:763, 1996) postulated factor V Leiden (FVL) to be an absolute prerequisite for the development of thromboembolism in patients with severe hyperhomocysteinemia. We studied 24 patients with homocystinuria caused by homozygous CBS deficiency from 18 unrelated kindreds for FVL and for the 677C-->T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and investigated their possible interaction in the risk of venous thrombosis. Thrombotic complications were diagnosed in six patients, of whom only one was a carrier of FVL. On the contrary, thermolabile MTHFR caused by the 677C-->T mutation, was frequently observed among homocystinuria patients, especially among those with thromboembolic complications: three of six homocystinuria patients who had suffered from a thromboembolic event had thermolabile MTHFR. These data indicate that FVL is not an absolute prerequisite and probably not even a major determinant of venous thrombosis in homocystinuria, but, interestingly, thermolabile MTHFR may constitute a significant risk factor for thromboembolic complications in this inborn error of methionine metabolism. (C) 1998 by The American Society of Hematology.
引用
收藏
页码:2015 / 2018
页数:4
相关论文
共 40 条
[1]   PLASMA HOMOCYSTEINE LEVELS IN PATIENTS WITH DEEP VENOUS THROMBOSIS [J].
AMUNDSEN, T ;
UELAND, PM ;
WAAGE, A .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (09) :1321-1323
[2]  
APPLEGARTH DA, 1971, NEW ENGL J MED, V285, P1265
[3]  
Arruda VR, 1997, THROMB HAEMOSTASIS, V77, P818
[4]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[5]   ELEVATED TOTAL PLASMA HOMOCYSTEINE, A RISK FACTOR FOR THROMBOSIS - RELATION TO COAGULATION AND FIBRINOLYTIC PARAMETERS [J].
BIENVENU, T ;
ANKRI, A ;
CHADEFAUX, B ;
MONTALESCOT, G ;
KAMOUN, P .
THROMBOSIS RESEARCH, 1993, 70 (02) :123-129
[6]   UNIQUE EFFICIENCY OF METHIONINE METABOLISM IN PREMENOPAUSAL WOMEN MAY PROTECT AGAINST VASCULAR-DISEASE IN THE REPRODUCTIVE YEARS [J].
BOERS, GH ;
SMALS, AG ;
TRIJBELS, FJ ;
LEERMAKERS, AI ;
KLOPPENBORG, PW .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (06) :1971-1976
[7]   IMPROVED IDENTIFICATION OF HETEROZYGOTES FOR HOMOCYSTINURIA DUE TO CYSTATHIONINE SYNTHASE DEFICIENCY BY THE COMBINATION OF METHIONINE LOADING AND ENZYME DETERMINATION IN CULTURED FIBROBLASTS [J].
BOERS, GHJ ;
FOWLER, B ;
SMALS, AGH ;
TRIJBELS, FJM ;
LEERMAKERS, AI ;
KLEIJER, WJ ;
KLOPPENBORG, PWC .
HUMAN GENETICS, 1985, 69 (02) :164-169
[8]  
BRATTSTROM L, 1991, HAEMOSTASIS, V21, P51
[9]  
Cattaneo M., 1996, Blood, V88, p285A
[10]  
DAngelo A, 1996, NEW ENGL J MED, V335, P289